Virus-Host Interactions: From Unbiased Genetic Screens to Function

Annual Review of Virology

Volumn 2, Issue , 2015, Pages 497-524

  Ramage, Holly ^a   Cherry, Sara ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiviral host factors; Gain of function screens; Haploid genetic screens; High throughput screening; Pro viral host factors; RNA interference

Indexed keywords

COMPLEMENTARY DNA; DEAD BOX PROTEIN; INTERFERON; PATTERN RECOGNITION RECEPTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 8; VIRUS DNA; VIRUS RNA;

AFFINITY PURIFICATION MASS SPECTROMETRY; ANDES VIRUS; BORNA DISEASE VIRUS; BUNYAVIRIDAE; DENGUE VIRUS; DROSOPHILA; DROSOPHILA C VIRUS; EBOLAVIRUS; ENTEROVIRUS B; FLOW CYTOMETRY; GENETIC SCREENING; HAPLOIDY; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; INFLUENZA; INNATE IMMUNITY; INTERFERON PRODUCTION; JUNIN VIRUS; LASSA VIRUS; MASS SPECTROMETRY; NEGATIVE-STRAND RNA VIRUS; NONHUMAN; ORTHOMYXOVIRIDAE; PAPILLOMAVIRIDAE; PHENOTYPE; POLIOMYELITIS VIRUS; POXVIRIDAE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REPORTER GENE; RETROVIRIDAE; REVIEW; RIFT VALLEY FEVER VIRUS; RNA INTERFERENCE; SINDBIS VIRUS; TRANSCRIPTOMICS; UUKUNIEMI VIRUS; VACCINIA VIRUS; VESICULOVIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION; WEST NILE VIRUS; YELLOW FEVER VIRUS; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; PATHOPHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY; VIRUS; VIRUS INFECTION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

EID: 84969169377     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-100114-055238     Document Type: Review

References (156)

1. Hannon GJ, Rossi JJ. 2004. Unlocking the potential of the human genome with RNA interference. Nature 431:371-78
2. Moffat J, Sabatini DM. 2006. Building mammalian signalling pathways with RNAi screens. Nat. Rev. Mol. Cell Biol. 7:177-87
3. Falschlehner C, Steinbrink S, Erdmann G, Boutros M. 2010. High-throughput RNAi screening to dissect cellular pathways: A how-to guide. Biotechnol. J. 5:368-76
4. Yasunaga A, Hanna SL, Li J,Cho H, Rose PP, et al. 2014. Genome-wide RNAi screen identifies broadlyacting host factors that inhibit arbovirus infection. PLOS Pathog. 10:e1003914
5. Panda D, Rose PP, Hanna SL, Gold B, Hopkins KC, et al. 2013. Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry. Cell Rep. 5:1737-48
6. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, et al. 2009. Discovery of insect and human dengue virus host factors. Nature 458:1047-50
7. Moser TS, Jones RG, Thompson CB, Coyne CB, Cherry S. 2010. A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics. PLOS Pathog. 6:e1000954
8. Panda D, Pascual-Garcia P, DunaginM, Tudor M, Hopkins KC, et al. 2014. Nup98 promotes antiviral gene expression to restrict RNA viral infection in Drosophila. PNAS 111:E3890-99
9. Mohr S, Bakal C, Perrimon N. 2010. Genomic screening with RNAi: results and challenges. Annu. Rev. Biochem. 79:37-64
10. Campeau E, Gobeil S. 2011. RNA interference in mammals: behind the screen. Brief. Funct. Genomics 10:215-26
11. Boutros M, Ahringer J. 2008. The art and design of genetic screens: RNA interference. Nat. Rev. Genet. 9:554-66
12. Hao L, He Q,Wang Z, Craven M, Newton MA, Ahlquist P. 2013. Limited agreement of independent RNAi screens for virus-required host genes owes more to false-negative than false-positive factors. PLOS Comput. Biol. 9:e1003235
13. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, et al. 2009. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLOS Pathog. 5:e1000437
14. Cherry S. 2009. What have RNAi screens taught us about viral-host interactions? Curr. Opin. Microbiol. 12:446-52
15. PandaD, Cherry S. 2012. Cell-based genomic screening: elucidating virus-host interactions. Curr. Opin. Virol. 2:784-92
16. Kotecki M, Reddy PS, Cochran BH. 1999. Isolation and characterization of a near-haploid human cell line. Exp. Cell Res. 252:273-80
17. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, et al. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477:340-43
18. Johnson SA, Hunter T. 2005. Kinomics: methods for deciphering the kinome. Nat. Methods 2:17-25
19. Hopkins AL, Groom CR. 2002. The druggable genome. Nat. Rev. Drug Discov. 1:727-30
20. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-26
21. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135:49-60
22. Zhou H, Xu M, HuangQ,Gates AT, Zhang XD, et al. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4:495-504
23. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. 2009. A genome-wide short hairpin RNA screening of Jurkat T-cells for human proteins contributing to productive HIV-1 replication. J. Biol. Chem. 284:19463-73
24. Nguyen DG, Yin H, Zhou Y, Wolff KC, Kuhen KL, Caldwell JS. 2007. Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening. Virology 362:16-25
25. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, et al. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-93
26. Brass AL, Huang IC, Benita Y, John SP, KrishnanMN, et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus,West Nile virus, and dengue virus. Cell 139:1243-54
27. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, et al. 2010. Human host factors required for influenza virus replication. Nature 463:813-17
28. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-22
29. Chin CR, Brass AL. 2013. A genome wide RNA interference screening method to identify host factors that modulate influenza A virus replication. Methods 59:217-24
30. Stertz S, Shaw ML. 2011. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect. 13:516-25
31. Mehle A, Doudna JA. 2010. A host of factors regulating influenza virus replication. Viruses 2:566-73
32. Min JY, Subbarao K. 2010. Cellular targets for influenza drugs. Nat. Biotechnol. 28:239-40
33. Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-39
34. Watanabe T, Kawakami E, Shoemaker JE, Lopes TJ, Matsuoka Y, et al. 2014. Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe 16:795-805
35. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-67
36. Elton D, Simpson-Holley M, Archer K, Medcalf L, Hallam R, et al. 2001. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 75:408-19
37. Neumann G, Hughes MT, Kawaoka Y. 2000. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 19:6751-58
38. Carette JE, Guimaraes CP, Varadarajan M, Park AS,Wuethrich I, et al. 2009. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326:1231-35
39. Hopkins KC, McLane LM, Maqbool T, Panda D, Gordesky-Gold B, Cherry S. 2013. A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching. Genes Dev. 27:1511-25
40. Meier R, Franceschini A, Horvath P, Tetard M, Mancini R, et al. 2014. Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration. J. Virol. 88:8565-78
41. Petersen J, DrakeMJ, Bruce EA, Riblett AM, Didigu CA, et al. 2014. Themajor cellular sterol regulatory pathway is required for Andes virus infection. PLOS Pathog. 10:e1003911
42. Emonet SF, de la Torre JC, Domingo E, Sevilla N. 2009. Arenavirus genetic diversity and its biological implications. Infect. Genet. Evol. 9:417-29
43. Ogbu O, Ajuluchukwu E,Uneke CJ. 2007. Lassa fever in West African sub-region: An overview. J. Vector Borne Dis. 44:1-11
44. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, et al. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for Lassa virus entry. Science 340:479-83
45. Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, et al. 2014. Lassa virus entry requires a trigger-induced receptor switch. Science 344:1506-10
46. LavanyaM, Cuevas CD, Thomas M, Cherry S, Ross SR. 2013. siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci. Transl.Med. 5:204ra131
47. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, et al. 2011. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. PNAS 108:19036-41
48. Lee AS, Burdeinick-Kerr R,Whelan SP. 2014. A genome-wide small interfering RNA screen identifies host factors required for vesicular stomatitis virus infection. J. Virol. 88:8355-60
49. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. 2009. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5:298-307
50. Ooi YS, Stiles KM, Liu CY, Taylor GM, Kielian M. 2013. Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry. PLOS Pathog. 9:e1003835
51. Lee AS, Burdeinick-Kerr R,Whelan SP. 2013. A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. PNAS 110:324-29
52. Clemente R, Sisman E, Aza-Blanc P, de laTorre JC. 2010. Identification of host factors involved in Borna disease virus cell entry through a small interfering RNA functional genetic screen. J. Virol. 84:3562-75
53. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, et al. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31:1947-60
54. Cote M, Misasi J, Ren T, Bruchez A, Lee K, et al. 2011. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477:344-48
55. Wakita T, Pietschmann T, Kato T, Date T,MiyamotoM, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-96
56. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. 2005. Robust hepatitis C virus infection in vitro. PNAS 102:9294-99
57. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, et al. 2009. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. PNAS 106:16410-15
58. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, et al. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. PNAS 104:12884-89
59. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, et al. 2011. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9:32-45
60. Li Q, Zhang YY, Chiu S, Hu Z, Lan KH, et al. 2014. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLOS Pathog. 10:e1004163
61. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-81
62. Vaillancourt FH, Pilote L, CartierM, Lippens J, Liuzzi M, et al. 2009. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 387:5-10
63. Ng TI, Mo H, Pilot-Matias T, He Y, Koev G, et al. 2007. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology 45:1413-21
64. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, et al. 2009. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. PNAS 106:7577-82
65. Supekova L, Supek F, Lee J, Chen S, Gray N, et al. 2008. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J. Biol. Chem. 283:29-36
66. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, et al. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17:589-95
67. Berger KL,Kelly SM, JordanTX, TartellMA, Randall G. 2011. HepatitisCvirus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J. Virol. 85:8870-83
68. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-86
69. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-5
70. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, et al. 1998. Binding of hepatitis C virus to CD81. Science 282:938-41
71. Ramage HR,Kumar GR,Verschueren E, Johnson JR,Von Dollen J, et al. 2015. A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay. Mol. Cell 57:329-40
72. Germain MA, Chatel-Chaix L, Gagne B, Bonneil E, Thibault P, et al. 2014. Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches. Mol. Cell. Proteomics 13:184-203
73. Balistreri G, Horvath P, Schweingruber C, Zund D, McInerney G, et al. 2014. The host nonsensemediated mRNA decay pathway restrictsmammalian RNA virus replication. Cell HostMicrobe 16:403-11
74. Garcia D, Garcia S, Voinnet O. 2014. Nonsense-mediated decay serves as a general viral restriction mechanism in plants. Cell Host Microbe 16:391-402
75. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, et al. 2008. RNA interference screen for human genes associated with West Nile virus infection. Nature 455:242-45
76. Gilfoy F, Fayzulin R, Mason PW. 2009. West Nile virus genome amplification requires the functional activities of the proteasome. Virology 385:74-84
77. Bhatt S,Gething PW, Brady OJ, Messina JP, Farlow AW, et al. 2013. The global distribution and burden of dengue. Nature 496:504-7
78. Li C, Wei J, Li Y,He X, ZhouQ, et al. 2013. Transmembrane protein 214 (TMEM214) mediates endoplasmic reticulum stress-induced caspase 4 enzyme activation and apoptosis. J. Biol. Chem. 288:17908-17
79. Le Sommer C, Barrows NJ, Bradrick SS, Pearson JL, Garcia-Blanco MA. 2012. G protein-coupled receptor kinase 2 promotes Flaviviridae entry and replication. PLOS Negl. Trop. Dis. 6:e1820
80. Schwartz O, Albert ML. 2010. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 8:491-500
81. Rose PP, Hanna SL, Spiridigliozzi A, Wannissorn N, Beiting DP, et al. 2011. Natural resistanceassociated macrophage protein is a cellular receptor for Sindbis virus in both insect and mammalian hosts. Cell Host Microbe 10:97-104
82. Whitton JL, Cornell CT, Feuer R. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3:765-76
83. Cherry S, Doukas T, Armknecht S,Whelan S, Wang H, et al. 2005. Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 19:445-52
84. Huang JY, Su WC, Jeng KS, Chang TH, Lai MM. 2012. Attenuation of 40S ribosomal subunit abundance differentially affects host and HCV translation and suppresses HCV replication. PLOS Pathog. 8:e1002766
85. Majzoub K, HafirassouML, Meignin C, Goto A,Marzi S, et al. 2014. RACK1 controls IRES-mediated translation of viruses. Cell 159:1086-95
86. Coyne CB, Bozym R, Morosky SA, Hanna SL, Mukherjee A, et al. 2011. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9:70-82
87. Swanson JA. 2008. Shaping cups into phagosomes andmacropinosomes. Nat. Rev. Mol. Cell Biol. 9:639-49
88. Bengali Z, Satheshkumar PS, Yang Z, Weisberg AS, Paran N, Moss B. 2011. Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription. PLOS ONE 6:e17248
89. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-35
90. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, et al. 2012. RNAi screening reveals proteasomeand Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2:1036-47
91. Sivan G, Martin SE, Myers TG, Buehler E, Szymczyk KH, et al. 2013. Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. PNAS 110:3519-24
92. Blasco R, Sisler JR, Moss B. 1993. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 67:3319-25
93. Hruby DE, Guarino LA, Kates JR. 1979. Vaccinia virus replication. I. Requirement for the host-cell nucleus. J. Virol. 29:705-15
94. Filone CM, Caballero IS, Dower K, Mendillo ML, Cowley GS, et al. 2014. The master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infection. PLOS Pathog. 10:e1003904
95. Kilcher S, Schmidt FI, Schneider C, Kopf M, Helenius A, Mercer J. 2014. siRNA screen of early poxvirus genes identifies the AAA+ATPase D5 as the virus genome-uncoating factor. CellHostMicrobe 15:103-12
96. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550-60
97. Aydin I,Weber S, Snijder B, Samperio Ventayol P, Kuhbacher A, et al. 2014. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLOS Pathog. 10:e1004162
98. Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, et al. 2013. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. PNAS 110:7452-57
99. DavisZH, VerschuerenE, JangGM, Kleffman K, Johnson JR, et al. 2015. Globalmapping of herpesvirushost protein complexes reveals a transcription strategy for late genes. Mol. Cell 57:349-60
100. Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated genes: A complex web of host defenses. Annu. Rev. Immunol. 32:513-45
101. Zhang Y, Burke CW, Ryman KD, Klimstra WB. 2007. Identification and characterization of interferoninduced proteins that inhibit alphavirus replication. J. Virol. 81:11246-55
102. Li J, Ding SC, Cho H, Chung BC, Gale M Jr, et al. 2013. A short hairpin RNA screen of interferonstimulated genes identifies a novel negative regulator of the cellular antiviral response. mBio 4:e00385-13
103. Zhao H, Lin W, Kumthip K, Cheng D, Fusco DN, et al. 2012. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. J. Hepatol. 56:326-33
104. Varble A, Benitez AA, Schmid S, Sachs D, Shim JV, et al. 2013. An in vivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 14:346-56
105. Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, et al. 2012. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 56:2082-93
106. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, et al. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79:13974-83
107. Jiang D, Guo H, Xu C, Chang J, Gu B, et al. 2008. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 82:1665-78
108. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, et al. 2010. Identification of five interferon-induced cellular proteins that inhibitWest Nile virus and dengue virus infections. J. Virol. 84:8332-41
109. Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, et al. 2006. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J. Viral Hepat. 13:690-700
110. Schoggins JW,Wilson SJ, Panis M, Murphy MY, Jones CT, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-85
111. Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G. 2012. Systematic identification of type I and type II interferon-induced antiviral factors. PNAS 109:4239-44
112. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, et al. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-95
113. Ooi EL, Chan ST, Cho NE, Wilkins C, Woodward J, et al. 2014. Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1. PNAS 111:1909-14
114. Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, et al. 2012. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. PNAS 109:14610-15
115. Karki S, LiMM,Schoggins JW,Tian S, Rice CM,MacDonald MR. 2012. Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLOS ONE 7:e37398
116. Sen GC, Sarkar SN. 2007. The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr. Top. Microbiol. Immunol. 316:233-50
117. Schoggins JW. 2014. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6:40-46
118. Randall RE, Goodbourn S. 2008. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47
119. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-25
120. Iwasaki A, Pillai PS. 2014. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14:315-28
121. Horner SM, Gale M Jr. 2013. Regulation of hepatic innate immunity by hepatitis C virus. Nat. Med. 19:879-88
122. Metz P, Reuter A, Bender S, Bartenschlager R. 2013. Interferon-stimulated genes and their role in controlling hepatitis C virus. J. Hepatol. 59:1331-41
123. Suthar MS, Aguirre S, Fernandez-Sesma A. 2013. Innate immune sensing of flaviviruses. PLOS Pathog. 9:e1003541
124. Rathinam VA, Fitzgerald KA. 2011. Innate immune sensing of DNA viruses. Virology 411:153-62
125. Sharma S, Fitzgerald KA. 2011. Innate immune sensing of DNA. PLOS Pathog. 7:e1001310
126. Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, et al. 2011. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 147:853-67
127. Amit I,GarberM,ChevrierN, Leite AP,Donner Y, et al. 2009. Unbiased reconstruction of amammalian transcriptional network mediating pathogen responses. Science 326:257-63
128. Lee MN, Roy M, Ong SE, Mertins P, Villani AC, et al. 2013. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14:179-85
129. Bürckstümmer T, Baumann C, Bluml S, Dixit E, Dürnberger G, et al. 2009. An orthogonal proteomicgenomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10:266-72
130. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5:ra20
131. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, et al. 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33:765-76
132. BeitingDP, Hidano S, Baggs JE,Geskes JM, Fang Q, et al. 2015. The orphan nuclear receptor TLX is an enhancer of STAT1-mediated transcription and immunity to Toxoplasma gondii. PLOS Biol. 13:e1002200
133. Lancaster KZ, Pfeiffer JK. 2010. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLOS Pathog. 6:e1000791
134. Sabin LR, Zhou R, Gruber JJ, Lukinova N, Bambina S, et al. 2009. Ars2 regulates both miRNA-and siRNA-dependent silencing and suppresses RNA virus infection in Drosophila. Cell 138:340-51
135. Gruber JJ, Zatechka DS, Sabin LR, Yong J, Lum JJ, et al. 2009. Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell 138:328-39
136. Hopkins KC, TartellMA, Herrmann C,Hackett BA, Taschuk F, et al. 2015. Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOPmRNAsrestricts viral infection. PNAS 112:E2920-29
137. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12:959-65
138. Zhang Z, Kim T, Bao M, Facchinetti V, Jung SY, et al. 2011. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 34:866-78
139. Miyashita M, Oshiumi H, Matsumoto M, Seya T. 2011. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol. Cell. Biol. 31:3802-19
140. Moy RH, Cole BS, Yasunaga A, Gold B, Shankarling G, et al. 2014. Stem-loop recognition by DDX17 facilitates miRNA processing and antiviral defense. Cell 158:764-77
141. Poenisch M, Metz P, Blankenburg H, Ruggieri A, Lee JY, et al. 2015. Identification of HNRNPK as regulator of hepatitis C virus particle production. PLOS Pathog. 11:e1004573
142. Gilsdorf M, Horn T, Arziman Z, Pelz O, Kiner E, Boutros M. 2010. GenomeRNAi: A database for cell-based RNAi phenotypes. 2009 update. Nucleic Acids Res. 38:D448-52
143. Ramo P, Drewek A, Arrieumerlou C, Beerenwinkel N, Ben-Tekaya H, et al. 2014. Simultaneous analysis of large-scale RNAi screens for pathogen entry. BMC Genomics 15:1162
144. Zhu J, Davoli T, Perriera JM, Chin CR, Gaiha GD, et al. 2014. Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents. Cell Rep. 9:752-66
145. Luo B, CheungHW,Subramanian A, Sharifnia T, OkamotoM, et al. 2008. Highly parallel identification of essential genes in cancer cells. PNAS 105:20380-85
146. Bürckstümmer T, Banning C, Hainzl P, Schobesberger R, Kerzendorfer C, et al. 2013. A reversible gene trap collection empowers haploid genetics in human cells. Nat. Methods 10:965-71
147. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262-78
148. Sander JD, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32:347-55
149. Doudna JA, Charpentier E. 2014. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096
150. Shalem O, Sanjana NE,Hartenian E, Shi X, Scott DA, et al. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84-87
151. Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, et al. 2011. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8:659-61
152. Wang Z, Gerstein M, Snyder M. 2009. RNA-Seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 10:57-63
153. Greco TM, Diner BA, Cristea IM. 2014. The impact of mass spectrometry-based proteomics on fundamental discoveries in virology. Annu. Rev. Virol. 1:581-604
154. Vinayavekhin N, Saghatelian A. 2010. Untargeted metabolomics. Curr. Protoc. Mol. Biol. 90:30.1.1-30.1.24
155. Davila S, Hibberd ML. 2009. Genome-wide association studies are coming for human infectious diseases. Genome Med. 1:19
156. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, et al. 2011. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12:745-55